Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593616 | SCV000707056 | pathogenic | not provided | 2017-03-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001054019 | SCV001218312 | pathogenic | Bethlem myopathy 1A | 2019-03-13 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with COL6A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 500904). Loss-of-function variants in COL6A2 are known to be pathogenic (PMID: 19884007, 20976770). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gly277Glufs*131) in the COL6A2 gene. It is expected to result in an absent or disrupted protein product. |